1. Home
  2. MDGL vs BOKF Comparison

MDGL vs BOKF Comparison

Compare MDGL & BOKF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • BOKF
  • Stock Information
  • Founded
  • MDGL 2011
  • BOKF 1910
  • Country
  • MDGL United States
  • BOKF United States
  • Employees
  • MDGL N/A
  • BOKF N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • BOKF Major Banks
  • Sector
  • MDGL Health Care
  • BOKF Finance
  • Exchange
  • MDGL Nasdaq
  • BOKF Nasdaq
  • Market Cap
  • MDGL 6.1B
  • BOKF 6.0B
  • IPO Year
  • MDGL N/A
  • BOKF N/A
  • Fundamental
  • Price
  • MDGL $427.10
  • BOKF $114.95
  • Analyst Decision
  • MDGL Strong Buy
  • BOKF Buy
  • Analyst Count
  • MDGL 10
  • BOKF 9
  • Target Price
  • MDGL $485.78
  • BOKF $115.00
  • AVG Volume (30 Days)
  • MDGL 294.9K
  • BOKF 214.9K
  • Earning Date
  • MDGL 10-30-2025
  • BOKF 10-20-2025
  • Dividend Yield
  • MDGL N/A
  • BOKF 1.99%
  • EPS Growth
  • MDGL N/A
  • BOKF 17.28
  • EPS
  • MDGL N/A
  • BOKF 8.36
  • Revenue
  • MDGL $515,547,000.00
  • BOKF $2,074,957,000.00
  • Revenue This Year
  • MDGL $394.08
  • BOKF $6.67
  • Revenue Next Year
  • MDGL $61.80
  • BOKF $7.10
  • P/E Ratio
  • MDGL N/A
  • BOKF $13.71
  • Revenue Growth
  • MDGL 3421.98
  • BOKF 4.66
  • 52 Week Low
  • MDGL $200.63
  • BOKF $85.08
  • 52 Week High
  • MDGL $463.63
  • BOKF $121.58
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 50.64
  • BOKF 60.99
  • Support Level
  • MDGL $425.60
  • BOKF $114.07
  • Resistance Level
  • MDGL $463.63
  • BOKF $117.42
  • Average True Range (ATR)
  • MDGL 14.91
  • BOKF 2.17
  • MACD
  • MDGL -4.55
  • BOKF 0.13
  • Stochastic Oscillator
  • MDGL 20.84
  • BOKF 66.04

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.

Share on Social Networks: